Pay in 4 interest-free payments of $12.00 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
The MPC inhibitor UK5099 increases the glucose excursion seen during an intraperitoneal glucose tolerance test in C57BLK mice
Delvaeye T
2-hydroxyglutarate (2HG)
δ and γ isoforms are 3 nM
Ledipasvir - CAS# 1256388-51-8 0153 The MPC inhibitor UK5099 increasesLedipasvir, also known as GS 5885, CAS No. 1256388 51 8, is an inhibitor of the hepatitis C virus NS5A protein and is a drug for the treatment of hepatitis C that was developed by Gilead Sciences. On October 10, 2014 the FDA approved the combination product ledipasvir 90 mg sofosbuvir 400 mg (trade name Harvoni). The ledipasvir sofosbuvir combination is a direct acting antiviral agent that interferes with HCV replication and can be used to treat
US$ 128.00
US$ 81.85
US$ 89.00
US$ 110.00
US$ 111.30
US$ 68.00
US$ 46.80